A comprehensive new analysis is shining a spotlight on Megalin , a powerful and highly versatile receptor that plays a central role in maintaining cellular balance , organ function , and overall human health. This emerging perspective positions Megalin as a critical regulator in processes ranging from nutrient transport to neuroprotection , offering fresh momentum for innovation in disease management.
At its core, Megalin operates as a multi-functional receptor responsible for receptor-mediated endocytosis , a process that allows cells to absorb essential molecules such as vitamins , hormones , and proteins . Found in key tissues including the kidney , brain , and epithelial systems , Megalin acts as a gatekeeper, ensuring that vital compounds are efficiently captured and reused rather than lost. Its structure, composed of multiple binding domains, enables interaction with a remarkably diverse range of ligands, highlighting its importance across biological systems.
The significance of Megalin becomes particularly evident in its connection to major health challenges. In the kidney , it supports protein reabsorption , preventing essential molecules from being excreted and maintaining metabolic stability. In the brain , Megalin contributes to the clearance of harmful substances, supporting neurological function and protecting against toxic accumulation. Its ability to interact with a wide spectrum of molecules places it at the center of mechanisms linked to neurodegenerative conditions , metabolic disorders , and renal diseases .
Equally important is Megalin’s involvement in drug interactions and toxic responses . Certain compounds can bind to the receptor and accumulate within cells, leading to cellular stress and tissue damage. This dual role—supporting essential uptake while also mediating harmful accumulation—underscores the delicate balance governed by Megalin and highlights the need for precise therapeutic strategies.
Advances in understanding the binding mechanisms of Megalin are opening new opportunities for innovation. By targeting how specific molecules interact with the receptor, emerging approaches aim to enhance beneficial pathways while limiting harmful ones. Concepts such as gene modulation , targeted therapies , and molecular intervention are being explored as ways to regulate Megalin activity and improve health outcomes across multiple conditions.
As a molecular hub connecting diverse biological systems, Megalin is redefining how complex diseases are understood. Its broad influence across organs and pathways signals a shift toward more integrated approaches in medicine, where targeting a single key regulator could transform treatment strategies.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 10.4 | Impact Factor: 14.6
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect ( https://www.sciencedirect.com/journal/genes-and-diseases ).
Submissions to Genes & Diseases may be made using Editorial Manager ( https://www.editorialmanager.com/gendis/default.aspx ).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases ( https://x.com/GenesNDiseases )
Reference
Xian Zhang, Zhijun Zhang, Receptor-mediated endocytosis by Megalin: Exploring its role in ligand interaction and disease mechanisms, Genes & Diseases, Volume 13, Issue 4, 2026, 101891, https://doi.org/10.1016/j.gendis.2025.101891
Funding
China Science and Technology Innovation 2030- Major Project 2022ZD0211701
China Science and Technology Innovation 2030- Major Project 2021ZD0200700
National Natural Science Foundation of China 82130042
National Natural Science Foundation of China 82471552
Shenzhen Science and Technology Serial Funds (Guangdong, China) GJHZ20210705141400002
Shenzhen Science and Technology Serial Funds (Guangdong, China) KCXFZ20211020164543006
Shenzhen Science and Technology Serial Funds (Guangdong, China) JCYJ20220818101615033
Shenzhen Science and Technology Serial Funds (Guangdong, China) ZDSYS20220606100606014
Shenzhen Science and Technology Serial Funds (Guangdong, China) KQTD20221101093608028
Genes & Diseases